Trials / Unknown
UnknownNCT05362266
Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization
Incidence and Risk Factors of in Hospital Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization Treatment: a Retrospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.
Conditions
Timeline
- Start date
- 2022-04-10
- Primary completion
- 2023-03-01
- Completion
- 2023-04-01
- First posted
- 2022-05-05
- Last updated
- 2022-05-05
Locations
2 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05362266. Inclusion in this directory is not an endorsement.